- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07890363
Gamified Home-Based Core Neuromuscular Training for Chronic Low Back Pain
Effect of a Gamified Home-Based Core Neuromuscular Training on Pain, Disability, and Core Endurance in Women With Chronic Nonspecific Low Back Pain: A Randomized Controlled Trial
This randomized controlled trial aims to evaluate the effects of gamified home-based core neuromuscular training on pain intensity, functional disability, core muscular endurance, and exercise adherence in women with chronic nonspecific low back pain. Participants will be randomly allocated in a 1:1 ratio to either a gamified intervention group or a non-gamified control group. Both groups will perform the same progressive core exercise program. The intervention group will use a digital application with gamification features, while the control group will perform the exercises without gamification. Outcomes will be assessed at baseline and week 4. The study will determine whether gamification provides additional benefits over conventional home-based exercise in improving clinical outcomes and exercise adherence in women with chronic nonspecific low back pain.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Chronic nonspecific low back pain is associated with persistent pain and functional disability. Although home-based core exercises are commonly used in rehabilitation, maintaining exercise adherence can be challenging. Gamification may enhance motivation and engagement through interactive digital features.
This randomized controlled trial will recruit women aged 18-45 years with chronic nonspecific low back pain lasting at least 12 weeks and a baseline moderate pain intensity or more. Participants will be randomly allocated in a 1:1 ratio to a gamified intervention group or a non-gamified control group. Both groups will complete the same progressive home-based core exercise program for 4 weeks, with three sessions per week lasting 20-30 minutes. Exercises will include plank, side plank, foot-elevated side plank, dead bug, and bird dog. The intervention group will use a digital app, while the control group will perform the exercises without gamification.
Assessments will be conducted at baseline and week 4. Pain intensity will be measured using the Numeric Pain Rating Scale, functional disability using the Oswestry Disability Index, core muscular endurance using trunk flexor, trunk extensor, and side-bridge tests, and adherence as the percentage of completed sessions. The study aims to recruit 60 participants. Data will be analyzed using linear mixed-effects models to compare changes between groups over time. Ethical approval was obtained before recruitment, and written informed consent will be obtained from all participants.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Zizi M. Ali, Phd
- Numéro de téléphone: +966118240798
- E-mail: zmibrahim@pnu.edu.sa
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Female participants aged 18-45 years.
- Nonspecific low back pain persisting for at least 12 weeks.
- Baseline pain intensity of ≥3 on the Numeric Pain Rating Scale (NPRS).
- Ability to perform the prescribed core exercises safely.
- Ownership of a compatible smartphone.
- Internet access when required.
Exclusion Criteria:
- Specific spinal pathology or serious medical conditions.
- Previous spinal surgery.
- Neurological symptoms affecting the lower limbs.
- Pregnancy.
- Severe musculoskeletal conditions limiting exercise.
- Current participation in another low back pain rehabilitation program.
- Any contraindication to exercise.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Arm 1: Gamified Intervention Group
A four-week home-based core neuromuscular exercise program using a digital application with gamification features. |
a six-week home-based core neuromuscular exercise program using a digital application with gamification features. The program will include three sessions per week, each lasting approximately 20-30 minutes. |
|
Comparateur actif: Arm 2: Non-Gamified Control Group
Participants will perform the same four-week home-based core neuromuscular exercise program without gamification, with three sessions per week, each lasting approximately 20-30 minutes. |
six-week home-based core neuromuscular exercise program without gamification, with three sessions per week, each lasting approximately 20-30 minutes. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Pain Intensity: Pain Rating Scale (NPRS)
Délai: Baseline to Week 4(4weeks).
|
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). Changes in pain intensity will be compared between the gamified and non-gamified home-based core neuromuscular training groups. Time Frame: |
Baseline to Week 4(4weeks).
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Oswestry Disability Index
Délai: Baseline to Week 4(4weeks)
|
The ODI is a validated, self-administered questionnaire used to assess functional disability associated with low back pain. It consists of 10 sections covering pain intensity and its impact on daily activities, including personal care, lifting, walking, sitting, standing, sleeping, sexual activity, social life, and traveling. Each section contains six response options scored from 0 (no disability) to 5 (maximum disability). The total score is calculated by summing the completed sections and converting it into a percentage: The total score is converted into a percentage by dividing the sum of the completed section scores by the maximum possible score (5 multiplied by the number of completed sections), then multiplying the result by 100. Higher percentages indicate greater functional disability. Interpretation: Minimal (0-20%), Moderate (21-40%), Severe (41-60%), Very severe (61-80%), and Extreme (81-100%). |
Baseline to Week 4(4weeks)
|
|
Core muscle endurance assessment 1
Délai: Baseline to Week 4(4weeks)
|
Trunk-Extensor-Test: hold time |
Baseline to Week 4(4weeks)
|
|
Core muscle endurance assessment 2
Délai: Baseline to Week 4(4weeks)
|
Trunk Flexor Test: hold time |
Baseline to Week 4(4weeks)
|
|
Core muscle endurance assessment 3
Délai: Baseline to Week 4(4weeks)
|
Side Bridge/Side Plank Test: hold time |
Baseline to Week 4(4weeks)
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 26-0740
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .